Multidrug resistance in new tuberculosis patients: Burden and implications

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 4, 2013, Pages 511-513

  Royce, S ^a   Falzon, D ^b   Van Weezenbeek, C ^c   Dara, M ^d   Hyder, K ^e   Hopewell, P ^a   Richardson, M D ^f   Zignol, M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c World Alliance for Patient Safety WHO   (United States)

^d European Communications Office   (Denmark)

^e South East Asia Regional Office ^*  (India)

^f Program for Appropriate Technology in Health   (United States)

Author keywords

Case finding; Drug susceptibility testing; Tuberculosis; Universal access

Indexed keywords

ARTICLE; AZERBAIJAN; BELARUS; BRAZIL; CHINA; DISEASE SURVEILLANCE; DRUG SENSITIVITY; ETHIOPIA; HEALTH CARE ACCESS; HUMAN; INDIA; INDONESIA; IRAN; KAZAKHSTAN; LUNG BURDEN; MOLDOVA; MOZAMBIQUE; MULTIDRUG RESISTANT TUBERCULOSIS; MYANMAR; NAMIBIA; NEPAL; PERU; PHILIPPINES; PRIORITY JOURNAL; RISK FACTOR; ROMANIA; RUSSIAN FEDERATION; SOUTH AFRICA; SOUTH KOREA; SWAZILAND; TAJIKISTAN; THAILAND; UGANDA; UKRAINE; UNITED STATES; UZBEKISTAN; VIET NAM; ZAMBIA; ZIMBABWE;

ANTITUBERCULAR AGENTS; DISEASE NOTIFICATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEALTH POLICY; HUMANS; MICROBIAL SENSITIVITY TESTS; POLICY MAKING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84875439339     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0286     Document Type: Article

References (9)

1. World Health Organization. Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 201-1.
2. World Health Assembly. Prevention and control of multidrugresistant tuberculosis and extensively drug-resistant tuberculosis. Agenda item 12.9. WHA 62.15. Geneva, Switzerland, 22 May 200-9.
3. World Health Organization, Stop TB Partnership. The Global Plan to Stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. Geneva, Switzerland: WHO, 201-0.
4. World Health Organization, Stop TB Department. Tuberculosis country profiles. Geneva, Switzerland: WHO, 2012. http://www.who.int/tb/country/data/ profiles/en/index.html Accessed February 201-2.
5. Zignol M, van Gemert W, Falzon D, et al. Surveillance of antituberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012; 90: 111-11-9.
6. World Health Organization. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drugresistant tuberculosis by 2015. WHO progress report 2011. WHO/HTM/TB/2011.3. Geneva, Switzerland: WHO, 201-1.
7. World Health Organization, Stop TB Department. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 201-0.
8. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373: 1861-187-3.
9. Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M. Modernizing surveillance of anti-tuberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011; 52: 901-90-6.